Prostate Cancer Awareness Month Breast Cancer Awareness Month: Get $300 off a Full Body or Full Body Plus if you book before October 31st.

Read more

Our mission is to detect cancer early for everyone in the world.

Early cancer detection increases survival rates to over 80%.

Of the 18.1 million people who will be diagnosed with cancer this year, half will be diagnosed late1. And the unfortunate reality is, patients who detect cancer late are much less likely to survive.

But there’s good news, too—our annual Full Body Scan can now bring the advantage of early cancer detection to more people at risk.

The Ezra Scan
Scan Results

Potential Intraductal Papillary Mucosal Neoplasm (IPMN)

We have found signs of IPMNs for our members. Left untreated, some IPMNs can turn into pancreatic cancer.

We have helped 13% of our members identify potential cancer early. Our goal is to scan one million people per year by 2030.


“We believe checking your body for cancer should be the easiest part of your health routine.”

Emi Gal

Co-founder & CEO

Emi is a software engineer and entrepreneur with a 15-year track record for building successful technology companies, and bringing them to a worldwide stage. Prior to Ezra, he launched Brainient, an advertising technology company that was acquired by Teads. Emi helped scale Teads to $1B in annual revenue as CEO of Teads Studio.

Diego Cantor

Co-founder & CTO

Diego holds a PhD in Biomedical Engineering and has 20 years of academic, research, and industry experience. During his doctoral research, Diego studied temporal lobe epilepsy and designed a breakthrough, non-invasive way to detect it and lateralize it in MRI. Prior to Ezra, he held a post-doctoral fellowship studying automatic recognition of anatomy in ultrasound, and prediction of tissue features in MRI with artificial intelligence.

The nation’s top researchers and doctors are helping Ezra become the new norm.

With the help of the nation’s top medical experts, we’ve designed MRI and low dose CT scanning protocols to help identify potential cancer in up to 13 organs.

Meet our Advisors

With the help of the nation’s top medical experts, we’ve designed MRI and low dose CT scanning protocols to help identify potential cancer in up to 13 organs.

Siddhartha Mukherjee, M.D., D.Phil.

Siddhartha Mukherjee, M.D., D.Phil.

Assistant Professor of Medicine
Columbia University Medical Center
Oguz Akin, M.D.

Oguz Akin, M.D.

Professor of Radiology
Memorial Sloan Kettering Cancer Center
Lawrence Tanenbaum, M.D., FACR

Lawrence Tanenbaum, M.D., FACR

Director of MRI, CT and Advanced Imaging

Want to join us?

Careers at Ezra
Recent Press Releases
Ezra Expands Full Body Cancer Screening Services to Miami, Florida

Miami, FL (June 10th 2021, 9:00am EDT) – Ezra, the AI startup transforming early

Read More
Introducing the Ezra Mammogram

New York, NY (May 18th, 2021) – Ezra, the NYC-based startup transforming early cancer

Read More
Ezra Introduces Prostate MRI With IV Contrast

Eligible Ezra Members will be offered the Ezra Prostate MRI with IV Contrast at

Read More
In the news
Our Investors

Esther Dyson

Executive Founder of Wellville

Board Member at 23andme

Daniel Dines

CEO & Founder of UiPath

Taavet Hinrikus

CEO & Co-Founder of TransferWise

Emma Robbins

Founder & CEO of Harvest Digital

Vlad Tenev

Co-Founder of Robinhood

Alexander Ljung

Founder & CEO of SoundCloud

Jeff Raider

Co-Founder & Co-CEO of Harry's

David Gilboa

Co-Founder & Co-CEO of Warby Parker

Fred Destin

Founder of Stride.VC

Jeremy Arditi

Chief Commercial Officer at Teads

Andrei Dunca

Co-founder & CTO at Liverail

Ben Barokas

Founder & CEO of Sourcepoint

Jason Goodman

CEO & co-founder of Eastnine

Ciprian Morar

Founder & CEO at Lateral

Punit Sarin

Head of Product at Liverail

Joshua Kazam

Co-founder & Partner of Two River